Cadrenal Therapeutics (CVKD) Company Overview

Profile

Full Name:

Cadrenal Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 20, 2023

Indexes:

Not included

Description:

Cadrenal Therapeutics focuses on developing innovative treatments for kidney diseases. The company aims to improve patient outcomes through advanced therapies and research, addressing unmet medical needs in the renal health sector. Their commitment to innovation drives their mission to enhance the quality of life for patients with kidney conditions.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 20, 2024

Analyst ratings

Recent major analysts updates

Nov 11, 24 HC Wainwright & Co.
Buy
Jun 6, 24 HC Wainwright & Co.
Buy
May 9, 24 HC Wainwright & Co.
Buy
Mar 14, 24 HC Wainwright & Co.
Buy
Dec 18, 23 Noble Capital Markets
Outperform
Nov 20, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Cadrenal Therapeutics?
  • Does Cadrenal Therapeutics pay dividends?
  • What sector is Cadrenal Therapeutics in?
  • What industry is Cadrenal Therapeutics in?
  • What country is Cadrenal Therapeutics based in?
  • When did Cadrenal Therapeutics go public?
  • Is Cadrenal Therapeutics in the S&P 500?
  • Is Cadrenal Therapeutics in the NASDAQ 100?
  • Is Cadrenal Therapeutics in the Dow Jones?
  • When does Cadrenal Therapeutics report earnings?
  • Should I buy Cadrenal Therapeutics stock now?

What is the ticker symbol for Cadrenal Therapeutics?

The ticker symbol for Cadrenal Therapeutics is NASDAQ:CVKD

Does Cadrenal Therapeutics pay dividends?

No, Cadrenal Therapeutics does not pay dividends

What sector is Cadrenal Therapeutics in?

Cadrenal Therapeutics is in the Healthcare sector

What industry is Cadrenal Therapeutics in?

Cadrenal Therapeutics is in the Biotechnology industry

What country is Cadrenal Therapeutics based in?

Cadrenal Therapeutics is headquartered in United States

When did Cadrenal Therapeutics go public?

Cadrenal Therapeutics's initial public offering (IPO) was on January 20, 2023

Is Cadrenal Therapeutics in the S&P 500?

No, Cadrenal Therapeutics is not included in the S&P 500 index

Is Cadrenal Therapeutics in the NASDAQ 100?

No, Cadrenal Therapeutics is not included in the NASDAQ 100 index

Is Cadrenal Therapeutics in the Dow Jones?

No, Cadrenal Therapeutics is not included in the Dow Jones index

When does Cadrenal Therapeutics report earnings?

The date for Cadrenal Therapeutics's next earnings report has not been announced yet

Should I buy Cadrenal Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions